9258 Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$369K Sell
4,407
-7
-0.2% -$552 0.05% 244
2024
Q2
$340K Hold
4,414
0.05% 247
2024
Q1
$302K Sell
4,414
-10
-0.2% -$643 0.05% 269
2023
Q4
$256K Sell
4,424
-33
-0.7% -$1.76K 0.05% 272
2023
Q3
$235K Buy
+4,457
New +$234K 0.05% 281
2022
Q3
Sell
-5,416
Closed -$202K 325
2022
Q2
$202K Buy
5,416
+235
+5% +$9.57K 0.05% 315
2022
Q1
$229K Sell
5,181
-4,370
-46% -$189K 0.05% 327
2021
Q4
$406K Sell
9,551
-380
-4% -$16K 0.09% 229
2021
Q3
$431K Hold
9,931
0.12% 195
2021
Q2
$425K Buy
9,931
+3,826
+63% +$161K 0.11% 197
2021
Q1
$236K Buy
+6,105
New +$231K 0.07% 280

Other funds holding BSX

9258 Wealth Management's BSX Position: Q3 2024 in Review

9258 Wealth Management reduced its Boston Scientific (BSX) stake by 0.16% in Q3 2024, selling an estimated $552 and leaving 4,407 shares worth $369K. The position accounts for 0.05% of the portfolio, ranked #244.

9258 Wealth Management first reported a position in BSX in Q1 2021 and has held it in 11 quarters since. The position peaked at $431K in Q3 2021. 1,395 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • 9258 Wealth Management held 4,407 shares of Boston Scientific worth $369K as of Q3 2024.
  • 9258 Wealth Management sold 7 Boston Scientific shares in Q3 2024, an estimated $552.
  • Boston Scientific made up 0.05% of 9258 Wealth Management's portfolio in Q3 2024, its #244 holding.
  • 9258 Wealth Management first reported a position in Boston Scientific in Q1 2021 and has held it in 11 quarters since.
  • 9258 Wealth Management's Boston Scientific position peaked at $431K in Q3 2021.
  • 1,395 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on 9258 Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.